195 related articles for article (PubMed ID: 36357802)
1. Prognostic Impact of Positive Peritoneal Lavage Cytology on Resectable Pancreatic Body and Tail Cancer: A Retrospective Study.
Mashiko T; Ogasawara T; Masuoka Y; Ei S; Takahashi S; Hirabayashi K; Mori M; Koyanagi K; Yamamoto S; Nakagohri T
World J Surg; 2023 Mar; 47(3):729-739. PubMed ID: 36357802
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of intraoperative peritoneal washing cytology for patients with potentially resectable pancreatic ductal adenocarcinoma.
Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Hoshi N; Hoshi S; Hirabayashi K; Ogata Y
Pancreatology; 2017; 17(1):109-114. PubMed ID: 27840175
[TBL] [Abstract][Full Text] [Related]
3. Should Positive Cytology Revealed by Intraoperative Lavage Preclude Radical Resection in Resectable Pancreatic Cancer?: A Systemic Review and Meta-analysis.
Li BQ; Wang HY; Li L; Jiang B; Ma CL; Yuan CH; Xiu DR
Pancreas; 2022 Nov-Dec 01; 51(10):1263-1276. PubMed ID: 37099766
[TBL] [Abstract][Full Text] [Related]
4. Prognostic importance of peritoneal washing cytology in patients with otherwise resectable pancreatic ductal adenocarcinoma who underwent pancreatectomy: A nationwide, cancer registry-based study from the Japan Pancreas Society.
Tsuchida H; Fujii T; Mizuma M; Satoi S; Igarashi H; Eguchi H; Kuroki T; Shimizu Y; Tani M; Tanno S; Tsuji Y; Hirooka Y; Masamune A; Mizumoto K; Itoi T; Egawa S; Kodama Y; Hamada S; Unno M; Yamaue H; Okazaki K;
Surgery; 2019 Dec; 166(6):997-1003. PubMed ID: 31445763
[TBL] [Abstract][Full Text] [Related]
5. The implications of positive peritoneal lavage cytology in potentially resectable pancreatic cancer.
Yoshioka R; Saiura A; Koga R; Arita J; Takemura N; Ono Y; Yamamoto J; Yamaguchi T
World J Surg; 2012 Sep; 36(9):2187-91. PubMed ID: 22555286
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications of peritoneal cytology in potentially resectable pancreatic cancer: positive peritoneal cytology may not confer an adverse prognosis.
Yamada S; Takeda S; Fujii T; Nomoto S; Kanazumi N; Sugimoto H; Kasuya H; Kodera Y; Nagasaka T; Morita S; Nakao A
Ann Surg; 2007 Aug; 246(2):254-8. PubMed ID: 17667504
[TBL] [Abstract][Full Text] [Related]
7. Value of peritoneal cytology in potentially resectable pancreatic cancer.
Yamada S; Fujii T; Kanda M; Sugimoto H; Nomoto S; Takeda S; Nakao A; Kodera Y
Br J Surg; 2013 Dec; 100(13):1791-6. PubMed ID: 24227366
[TBL] [Abstract][Full Text] [Related]
8. Implications of peritoneal lavage cytology in resectable left-sided pancreatic cancer.
Iwagami Y; Eguchi H; Wada H; Tomimaru Y; Hama N; Kawamoto K; Kobayashi S; Mori M; Doki Y; Nagano H
Surg Today; 2015 Apr; 45(4):444-50. PubMed ID: 24975140
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of positive peritoneal cytology in resectable pancreatic cancer: a systemic review and meta-analysis.
Cao F; Li J; Li A; Li F
Oncotarget; 2017 Feb; 8(9):15004-15013. PubMed ID: 28122342
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of high-quality testing for peritoneal lavage cytology in pancreatic cancer.
Tanemura M; Furukawa K; Mikamori M; Asaoka T; Yasuoka H; Marukawa D; Urata Y; Yamada D; Kobayashi S; Eguchi H
Sci Rep; 2024 May; 14(1):10199. PubMed ID: 38702437
[TBL] [Abstract][Full Text] [Related]
11. Predictive impacts of peritoneal washing cytology for surgical resection-intended pancreatic cancer cases: Establishment of planned staging laparoscopy criteria.
Tanaka N; Takami H; Hayashi M; Inokawa Y; Kurimoto K; Hattori N; Kanda M; Tanaka C; Nakayama G; Kodera Y
J Hepatobiliary Pancreat Sci; 2023 Nov; 30(11):1273-1281. PubMed ID: 37799038
[TBL] [Abstract][Full Text] [Related]
12. The impact of peritoneal lavage cytology in biliary tract cancer (KHBO1701): Kansai Hepato-Biliary Oncology Group.
Matsukuma S; Nagano H; Kobayashi S; Wada H; Seo S; Tsugawa D; Okuyama H; Iida K; Ohmura Y; Takeda Y; Miyamoto A; Nakashima S; Yamada T; Ajiki T; Tsuji A; Yoshimura K; Eguchi H; Hatano E; Ioka T;
Cancer Rep (Hoboken); 2021 Apr; 4(2):e1323. PubMed ID: 33283475
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Peritoneal Lavage Cytology in Potentially Resectable Pancreatic Cancer Stratified by Cytologic Status.
Ishida H; Ogura T; Takahashi A; Kitamura K; Miyamoto R; Matsudaira S; Tanabe M; Kanda H; Kawashima Y
Cancer Diagn Progn; 2023; 3(3):338-346. PubMed ID: 37168974
[TBL] [Abstract][Full Text] [Related]
14. Positive peritoneal lavage cytology is a predictor of worse survival in locally advanced pancreatic cancer.
Clark CJ; Traverso LW
Am J Surg; 2010 May; 199(5):657-62. PubMed ID: 20466112
[TBL] [Abstract][Full Text] [Related]
15. Tumor location, clinicopathological features, and perioperative and prognostic outcomes in patients who underwent pancreatic resection following neoadjuvant chemoradiotherapy for resectable pancreatic cancer: A retrospective study.
Suto H; Matsukawa H; Fuke T; Nagao M; Ando Y; Oshima M; Yamana H; Kamada H; Kobara H; Okuyama H; Kumamoto K; Okano K
Pancreatology; 2024 May; 24(3):431-436. PubMed ID: 38383175
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Peritoneal Lavage Cytology in Patients with Pancreatic Ductal Adenocarcinoma Stratified by the Resectability Status.
Sakoda T; Uemura K; Kondo N; Sumiyoshi T; Okada K; Seo S; Otsuka H; Murakami Y; Takahashi S
J Gastrointest Surg; 2021 Nov; 25(11):2871-2880. PubMed ID: 33768425
[TBL] [Abstract][Full Text] [Related]
17. Intraperitoneal exfoliated cancer cells in patients with colorectal cancer.
Hase K; Ueno H; Kuranaga N; Utsunomiya K; Kanabe S; Mochizuki H
Dis Colon Rectum; 1998 Sep; 41(9):1134-40. PubMed ID: 9749497
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for peritoneal dissemination of gastric cancer.
Yeldan E; Oguz S; Usta U; Ilhan E; Senlikci A
Minerva Chir; 2015 Apr; 70(2):91-6. PubMed ID: 25815699
[TBL] [Abstract][Full Text] [Related]
19. Peritoneal cytology does not increase the prognostic information provided by TNM in gastric cancer.
de Manzoni G; Verlato G; Di Leo A; Tomezzoli A; Pedrazzani C; Pasini F; Piubello Q; Cordiano C
World J Surg; 2006 Apr; 30(4):579-84. PubMed ID: 16568221
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-593-3p Expression in Peritoneal Lavage Fluid as a Prognostic Marker for Pancreatic Cancer Patients Undergoing Staging Laparoscopy.
Hata T; Mizuma M; Masuda K; Chiba K; Ishida M; Ohtsuka H; Nakagawa K; Morikawa T; Kamei T; Unno M
Ann Surg Oncol; 2021 Apr; 28(4):2235-2245. PubMed ID: 33393045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]